Copyright
©The Author(s) 2024.
World J Diabetes. Jul 15, 2024; 15(7): 1562-1588
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1562
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1562
Serial number | MOL ID | Ingredient | Degree |
HQ4 | MOL000371 | 3,9-di-O-methylnissolin | 66.0 |
HQ6 | MOL000354 | Isorhamnetin | 63.0 |
HQ9 | MOL000239 | Jaranol | 63.0 |
HQ10, HL12 | MOL000098 | Quercetin | 62.0 |
HQ13 | MOL000422 | 1,7-Dihydroxy-3,9-dimethoxy pterocarpene | 62.0 |
HQ11 | MOL000438 | (3R)-3-(2-hydroxy-3,4-dimethoxyphenyl)chroman-7-ol | 58.0 |
HL11 | MOL000785 | Palmatine | 58.0 |
HL10 | MOL013352 | Obacunone | 57.0 |
HL9 | MOL008647 | Moupinamide | 56.0 |
- Citation: Zhang MY, Zheng SQ. Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease. World J Diabetes 2024; 15(7): 1562-1588
- URL: https://www.wjgnet.com/1948-9358/full/v15/i7/1562.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i7.1562